The development of the product development process
There has been a significant change in the development of new products in the healthcare industry over the last few years. The influence of IT, new tools, technologies, and the genome has enriched the development possibilities and irreversibly changed the clinical trials environment. Embracing a more patient-centric mindset and embedding innovation is central to this transformation. This requires collaboration from all stakeholders and an exchange of information in real time.
Development of a Point-of-Care (PoC) Testing Tool
New, advanced, highly-stable and ultra-sensitive technology will allow parameters to be evaluated at a higher speed in a portable manner, allowing patients to obtain key parameters at home which are transferred automatically to their MDs.
Development of a New Intelligent Antibiotic
A new development in antibiotic therapy using a different mechanism of action to fight the growing problem of antibiotic resistance. The next stage in antibiotic therapy is not to develop stronger antibiotics but ones which use other action mechanisms.
Identifying Immunomodulatory Substances
The recent pandemic situation made the present lack of effective antiviral therapy very evident. The natural immune system remains the strongest weapon against viral infections and any substance that could support its activity will benefit the fight of viral infections.
Immune Precision Medicine
for Cancer
Cancer cell growth is associated with immune surveillance failure. Nowadays, restoring the desired immune response against cancer cells remains a major therapeutic strategy. IDRE is involved in the search for a new product.